Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 8:00 PM View:  | O'Neill Gilmore Neil CEO Director | Editas Medicine, Inc. (EDIT) | 05-Mar-24 | Sale | 77,824 | $9.42 | $732,884.00 | (19%) 405.29K to 327.47K | |
| 05-Mar-24 7:54 PM View: | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Editas Medicine, Inc. (EDIT) | 04-Mar-24 | Sale | 20,327 | $9.42 | $191,425.00 | (13%) 161.87K to 141.54K | |
| 05-Mar-24 8:06 PM View: | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 02-Mar-24 | Grant | 61,266 | -- | -- | 79% 77.9K to 139.17K | |
| 05-Mar-24 7:54 PM View: | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Editas Medicine, Inc. (EDIT) | 02-Mar-24 | Grant | 89,815 | -- | -- | 125% 72.06K to 161.87K | |
| 05-Mar-24 8:03 PM View: | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Editas Medicine, Inc. (EDIT) | 02-Mar-24 | Grant | 39,855 | -- | -- | 88% 45.17K to 85.02K | |
| 05-Mar-24 8:00 PM View: | O'Neill Gilmore Neil CEO Director | Editas Medicine, Inc. (EDIT) | 02-Mar-24 | Grant | 275,125 | -- | -- | 211% 130.17K to 405.29K | |
| 07-Dec-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 05-Dec-23 | Sale | 103 | $10.90 | $1,122.41 | (< 1%) 74.89K to 74.79K | |
| 16-Nov-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 14-Nov-23 | Sale | 695 | $8.21 | $5,705.67 | (< 1%) 75.59K to 74.89K | |
| 09-Nov-23 4:31 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 07-Nov-23 | Sale | 139 | $8.40 | $1,167.60 | (< 1%) 75.73K to 75.59K | |
| 07-Sep-23 4:59 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 06-Sep-23 | Sale | 103 | $8.82 | $908.46 | (< 1%) 75.83K to 75.73K | |
| 15-Aug-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 11-Aug-23 | Sale | 702 | $8.59 | $6,032.64 | (< 1%) 76.53K to 75.83K | |
| 10-Aug-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 08-Aug-23 | Sale | 141 | $8.39 | $1,182.99 | (< 1%) 76.67K to 76.53K | |
| 25-Jul-23 4:45 PM View: | Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER | Editas Medicine, Inc. (EDIT) | 24-Jul-23 | Grant | 45,167 | -- | -- | 100% 0 to 45.17K | |
| 21-Jul-23 4:30 PM View: | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Editas Medicine, Inc. (EDIT) | 19-Jul-23 | Sale | 4,317 | $8.80 | $37,989.60 | (6%) 76.37K to 72.06K | |
| 07-Jun-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 05-Jun-23 | Sale | 105 | $9.50 | $997.82 | (< 1%) 76.78K to 76.67K | |
| 07-Jun-23 4:30 PM View: | O'Neill Gilmore Neil CEO Director | Editas Medicine, Inc. (EDIT) | 05-Jun-23 | Sale | 6,486 | $9.50 | $61,637.80 | (5%) 136.66K to 130.17K | |
| 18-May-23 5:20 PM View: | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 17-May-23 | Grant | 77,900 | -- | -- | 100% 0 to 77.9K | |
| 15-May-23 4:30 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 11-May-23 | Sale | 949 | $9.87 | $9,368.53 | (< 1%) 107.56K to 106.61K | |
| 15-May-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 11-May-23 | Sale | 668 | $9.87 | $6,594.50 | (< 1%) 77.45K to 76.78K | |
| 11-May-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 09-May-23 | Sale | 135 | $9.51 | $1,283.85 | (< 1%) 77.58K to 77.45K | |
| 06-Mar-23 4:30 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 03-Mar-23 | Sale | 184 | $8.89 | $1,635.76 | (< 1%) 107.74K to 107.56K | |
| 06-Mar-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 03-Mar-23 | Sale | 101 | $8.89 | $897.89 | (< 1%) 77.68K to 77.58K | |
| 06-Mar-23 4:30 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 02-Mar-23 | Grant | 31,500 | -- | -- | 41% 76.24K to 107.74K | |
| 06-Mar-23 4:30 PM View: | O'Neill Gilmore Neil CEO Director | Editas Medicine, Inc. (EDIT) | 02-Mar-23 | Grant | 50,000 | -- | -- | 58% 86.66K to 136.66K | |
| 06-Mar-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 02-Mar-23 | Grant | 16,700 | -- | -- | 27% 60.98K to 77.68K | |
| 06-Mar-23 4:30 PM View: | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Editas Medicine, Inc. (EDIT) | 02-Mar-23 | Grant | 18,000 | -- | -- | 31% 58.37K to 76.37K | |
| 15-Feb-23 4:30 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 13-Feb-23 | Sale | 4,287 | $9.67 | $41,435.10 | (5%) 80.53K to 76.24K | |
| 15-Feb-23 4:30 PM View: | Shearman Mark S EVP, Chief Scientific Officer | Editas Medicine, Inc. (EDIT) | 13-Feb-23 | Sale | 2,790 | $9.67 | $26,966.20 | (4%) 68.35K to 65.56K | |
| 15-Feb-23 10:00 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 13-Feb-23 | Sale | 3,307 | $9.67 | $31,963.10 | (5%) 64.29K to 60.98K | |
| 09-Feb-23 4:30 PM View: | Eaton Bruce EVP, CBO AND CTO | Editas Medicine, Inc. (EDIT) | 07-Feb-23 | Sale | 346 | $11.10 | $3,840.60 | (< 1%) 64.64K to 64.29K | |
| 12-Jan-23 4:30 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 10-Jan-23 | Sale | 1,752 | $8.16 | $14,296.50 | (2%) 82.28K to 80.53K | |
| 06-Dec-22 4:30 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 05-Dec-22 | Sale | 193 | $10.23 | $1,974.39 | (< 1%) 82.47K to 82.28K | |
| 06-Dec-22 4:30 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 05-Dec-22 | Sale | 102 | $10.23 | $1,043.46 | (< 1%) 64.74K to 64.64K | |
| 09-Nov-22 4:30 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 08-Nov-22 | Sale | 289 | $11.02 | $3,184.78 | (< 1%) 65.03K to 64.74K | |
| 08-Sep-22 4:30 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 06-Sep-22 | Sale | 101 | $15.01 | $1,516.01 | (< 1%) 65.13K to 65.03K | |
| 08-Sep-22 4:30 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 06-Sep-22 | Sale | 192 | $15.01 | $2,881.92 | (< 1%) 82.67K to 82.47K | |
| 10-Aug-22 4:30 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 09-Aug-22 | Sale | 293 | $18.60 | $5,449.39 | (< 1%) 65.42K to 65.13K | |
| 20-Jul-22 4:36 PM View: | Mei Baisong SVP, CHIEF MEDICAL OFFICER | Editas Medicine, Inc. (EDIT) | 18-Jul-22 | Grant | 58,372 | -- | -- | 100% 0 to 58.37K | |
| 16-Jun-22 4:15 PM View: | Shearman Mark S EVP, Chief Scientific Officer | Editas Medicine, Inc. (EDIT) | 15-Jun-22 | Sale | 5,145 | $10.06 | $51,744.80 | (7%) 73.49K to 68.35K | |
| 06-Jun-22 4:45 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 03-Jun-22 | Sale | 1,527 | $11.54 | $17,616.80 | (2%) 84.19K to 82.67K | |
| 06-Jun-22 4:46 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 03-Jun-22 | Sale | 1,123 | $11.54 | $12,955.90 | (2%) 66.54K to 65.42K | |
| 06-Jun-22 4:44 PM View: | O'Neill Gilmore Neil CEO Director | Editas Medicine, Inc. (EDIT) | 02-Jun-22 | Grant | 86,655 | -- | -- | 100% 0 to 86.66K | |
| 11-May-22 4:15 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 09-May-22 | Sale | 297 | $13.11 | $3,894.50 | (< 1%) 66.84K to 66.54K | |
| 04-Apr-22 4:30 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 01-Apr-22 | Sale | 1,258 | $19.64 | $24,707.40 | (2%) 68.1K to 66.84K | |
| 07-Mar-22 4:15 PM View: | Robertson Michelle EVP, CHIEF FINANCIAL OFFICER | Editas Medicine, Inc. (EDIT) | 03-Mar-22 | Sale | 767 | $17.33 | $13,290.30 | (< 1%) 84.96K to 84.19K | |
| 07-Mar-22 4:15 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 03-Mar-22 | Sale | 403 | $17.33 | $6,983.06 | (< 1%) 68.79K to 68.39K | |
| 11-Feb-22 4:21 PM View: | Shearman Mark S EVP, Chief Scientific Officer | Editas Medicine, Inc. (EDIT) | 10-Feb-22 | Grant | 31,709 | -- | -- | 76% 41.78K to 73.49K | |
| 11-Feb-22 4:20 PM View: | Robertson Michelle Chief Financial Officer | Editas Medicine, Inc. (EDIT) | 10-Feb-22 | Grant | 53,499 | -- | -- | 170% 31.46K to 84.96K | |
| 11-Feb-22 4:22 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 10-Feb-22 | Grant | 37,593 | -- | -- | 121% 31.2K to 68.79K | |
| 10-Feb-22 4:36 PM View: | Eaton Bruce EVP, Chief Business Officer | Editas Medicine, Inc. (EDIT) | 08-Feb-22 | Sale | 302 | $17.63 | $5,323.08 | (< 1%) 31.5K to 31.2K |
